Thursday August 16, 2018

Diabetic Women at Greater Risk of Developing Cancer Than Men, According to a New Study

Overall, it was calculated that women with diabetes were six per cent more likely to develop any form of cancer than men with diabetes

0
//
11
The researchers found that women with diabetes were 27 per cent more likely to develop cancer than women without diabetes but for men the risk was 19 per cent higher.
The researchers found that women with diabetes were 27 per cent more likely to develop cancer than women without diabetes but for men the risk was 19 per cent higher. Pixabay
Republish
Reprint

Women suffering from diabetes may be at a higher risk of developing cancer than men, a new study has found.

The findings suggested that among the study participants, women with diabetes (Type 1 and Type 2) were at higher risks for developing kidney cancer (11 per cent), oral cancer (13 per cent), stomach cancer (14 per cent) and leukaemia (15 per cent) compared to men with the similar condition.

Diabetes affects more than 415 million people worldwide, with five million deaths every year.

According to the researchers, it is believed that heightened blood glucose may have cancer-causing effects by leading to DNA damage.

“The link between diabetes and the risk of developing cancer is now firmly established,” said lead author Toshiaki Ohkuma from The George Institute for Global Health in Australia.

They also found that diabetes was a risk factor for the majority of cancers of specific parts of the body for both men and women.
They also found that diabetes was a risk factor for the majority of cancers of specific parts of the body for both men and women. Pixabay

“The number of people with diabetes has doubled globally in the last 30 years but we still have much to learn about the condition,” Ohkuma added.

For the study, published in the journal Diabetologia, the researchers examined data on all-site cancer events (incident or fatal only) from 121 cohorts that included 19,239,302 individuals.

The researchers found that women with diabetes were 27 per cent more likely to develop cancer than women without diabetes but for men the risk was 19 per cent higher.

Also Read: Eating Dinner Early May Lower Risk of Breast, Prostate Cancer

They also found that diabetes was a risk factor for the majority of cancers of specific parts of the body for both men and women.

Overall, it was calculated that women with diabetes were six per cent more likely to develop any form of cancer than men with diabetes.

“It’s vital that we undertake more research into discovering what is driving this, and for both people with diabetes and the medical community to be aware of the heightened cancer risk for women and men with diabetes,” Ohkuma noted. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Epidurals Can be Cut Into Half, with the Help of a New Labour Pain Relieving Drug

It did not cause any negative effects for the mother or baby.

0
Labour pain relieving drug may cut need for epidural: Lancet
Labour pain relieving drug may cut need for epidural: Lancet. Flickr

Prescribing women a new drug called remifentanil to help manage their labour pain may halve the need for an epidural than the traditional pethidine, claims a study.

The study, published in the Lancet, suggested that using remifentanil instead of pethidine could reduce the need for epidurals, instrumental deliveries and consequent morbidity for large numbers of women worldwide.

Epidurals — injections of pain relief drugs around the spinal cord — provide effective pain relief but increase the risk of needing instrumental delivery (forceps or vacuum) during birth.

It can also increase the risk of trauma and long-lasting problems for the mother, such as incontinence and sexual dysfunction.

“Our findings challenge the routine use of pethidine for pain relief during labour,” said lead author Matthew Wilson, from Britain’s University of Sheffield.

"Remifentanil reduced the need for an epidural by half and there were no lasting problems for the mothers and babies
“Remifentanil reduced the need for an epidural by half and there were no lasting problems for the mothers and babies. Pixabay

“Remifentanil reduced the need for an epidural by half and there were no lasting problems for the mothers and babies in our trial, although the effect of remifentanil on maternal oxygen levels needs to be clarified in further studies,” he added.

Remifentanil is rarely offered routinely in labour and its use restricted to women who cannot receive an epidural for medical reasons (such as blood clotting disorders).

Conversely, pethidine has been in widespread use since the 1950s, even after long been known not helpful to all women.

The study included 400 women aged over 16 years old who were giving birth after 37 weeks.

Only half as many women in the remifentanil group went on to have an epidural (19 per cent) than in the pethidine group (41 per cent).

Remifentanil instead of pethidine could reduce the need for epidurals. Flickr
Remifentanil instead of pethidine could reduce the need for epidurals. Flickr

These women rated their pain as less severe and also had less likely to need forceps and vacuum during labour than women given pethidine (15 per cent vs 26 per cent).

Also Read: Obesity During Pregnancy May up Kid’s Risk of Epilepsy

However, remifentanil was associated with twice as many mothers having low oxygen levels than pethidine (14 per cent vs 5 per cent)

But, despite this increase it did not cause any negative effects for the mother or baby, but more research in larger groups will be needed to confirm this, the researchers said.(IANS)